Trials / Terminated
TerminatedNCT03416023
Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy
Prospective Multicentre Open Clinical Study to Assess the Safety Performance and Durability of the TIES® Transcutaneous Titanium Implant in Patients Requiring a Permanent Ileostomy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Ostomycure AB · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study to assess the safety, performance and durability of the TIES® transcutaneous titanium implant in patients requiring a permanent ileostomy.
Detailed description
This is a multicentre, open-label, single-arm clinical study that will assess the safety, performance and durability of the TIES® transcutaneous titanium implant in patients requiring a permanent ileostomy (a surgical procedure that involves connecting the small intestine to the skin to create an opening). The Transcutaneous Implant Evacuation System (TIES®) is a medical device designed to enable continence control for patients who would otherwise need to wear an ileostomy bag. Eligible subjects will undergo a conventional ileostomy procedure under general anaesthesia and have the TIES® Port implanted. To date, the TIES® has been evaluated in 11 patients in 2 clinical studies. This study aims to collect more data that will assess performance, durability, safety and the impact that the TIES® has on a patient's quality of life. The study will enroll 50 patients across Europe that require a permanent ileostomy, including patients with ulcerative colitis, familial adenomatous polyposis coli or other diseases such as Crohn´s disease. Study subjects are expected to participate for approximately 1 year following surgical placement of the TIES® Port. Participation will involve a screening period, surgical implantation of the device (in-patient) and scheduled follow-up assessments out to 1 year post implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TIES® (Transcutaneous Implant Evacuation System) | Transcutaneous Implant Evacuation System |
Timeline
- Start date
- 2018-10-30
- Primary completion
- 2023-11-15
- Completion
- 2023-11-15
- First posted
- 2018-01-30
- Last updated
- 2025-03-11
- Results posted
- 2025-02-17
Locations
4 sites across 2 countries: Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT03416023. Inclusion in this directory is not an endorsement.